8-Methoxy-6-(7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl)-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1(2H)-one
98%
- Product Code: 202789
CAS:
2403733-82-2
| Molecular Weight: | 504.50 g./mol | Molecular Formula: | C₂₅H₂₇F₃N₄O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD34789484 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
Used in pharmaceutical research as a potent and selective inhibitor of ALK (anaplastic lymphoma kinase), showing promise in the development of targeted cancer therapies, particularly for non-small cell lung cancer (NSCLC) and other ALK-driven tumors. Its structure enables high binding affinity and improved pharmacokinetic properties, making it suitable for oral administration in preclinical studies. Also investigated for overcoming resistance mutations in ALK, including the common G1202R mutation, where traditional inhibitors lose efficacy. Currently utilized in experimental models to evaluate tumor growth suppression and central nervous system penetration for potential treatment of brain metastases.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1mg | 10-20 days | ฿14,000.00 |
+
-
|
| 5mg | 10-20 days | ฿41,000.00 |
+
-
|
8-Methoxy-6-(7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl)-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1(2H)-one
Used in pharmaceutical research as a potent and selective inhibitor of ALK (anaplastic lymphoma kinase), showing promise in the development of targeted cancer therapies, particularly for non-small cell lung cancer (NSCLC) and other ALK-driven tumors. Its structure enables high binding affinity and improved pharmacokinetic properties, making it suitable for oral administration in preclinical studies. Also investigated for overcoming resistance mutations in ALK, including the common G1202R mutation, where traditional inhibitors lose efficacy. Currently utilized in experimental models to evaluate tumor growth suppression and central nervous system penetration for potential treatment of brain metastases.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :